Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck's Keytruda, up for new FDA nod, spurs lengthy responses in small cell lung cancer

fiercepharmaApril 02, 2019

Tag: Merck , FDA nod , small cell lung cancer

PharmaSources Customer Service